2024-06-01 2025-05-31 false Capium Accounts Production 1.1 12027503 2024-06-01 2025-05-31 12027503 bus:FullAccounts 2024-06-01 2025-05-31 12027503 bus:FRS102 2024-06-01 2025-05-31 12027503 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 12027503 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 12027503 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12027503 2024-06-01 2025-05-31 12027503 2025-05-31 12027503 bus:RegisteredOffice 2024-06-01 2025-05-31 12027503 core:WithinOneYear 2025-05-31 12027503 core:AfterOneYear 2025-05-31 12027503 1 2024-06-01 2025-05-31 12027503 bus:Director1 2024-06-01 2025-05-31 12027503 bus:Director1 2025-05-31 12027503 bus:Director1 2023-06-01 2024-05-31 12027503 2023-06-01 12027503 bus:LeadAgentIfApplicable 2024-06-01 2025-05-31 12027503 2023-06-01 2024-05-31 12027503 2024-05-31 12027503 core:WithinOneYear 2024-05-31 12027503 core:AfterOneYear 2024-05-31 12027503 bus:EntityAccountantsOrAuditors 2023-06-01 2024-05-31 12027503 bus:OrdinaryShareClass1 2024-06-01 2025-05-31 12027503 bus:OrdinaryShareClass1 2025-05-31 12027503 bus:OrdinaryShareClass1 2023-06-01 2024-05-31 12027503 bus:OrdinaryShareClass1 2024-05-31 12027503 core:ComputerEquipment 2024-06-01 2025-05-31 12027503 core:ComputerEquipment 2025-05-31 12027503 core:ComputerEquipment 2024-05-31 12027503 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-05-31 12027503 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-05-31 12027503 core:CostValuation core:Non-currentFinancialInstruments 2025-05-31 12027503 core:CostValuation core:Non-currentFinancialInstruments 2024-05-31 12027503 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-05-31 12027503 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-05-31 12027503 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-05-31 12027503 core:Non-currentFinancialInstruments 2025-05-31 12027503 core:Non-currentFinancialInstruments 2024-05-31 12027503 core:ShareCapital 2025-05-31 12027503 core:ShareCapital 2024-05-31 12027503 core:RetainedEarningsAccumulatedLosses 2025-05-31 12027503 core:RetainedEarningsAccumulatedLosses 2024-05-31 12027503 dpl:Item1 2024-06-01 12027503 dpl:Item1 2025-05-31 12027503 dpl:Item1 2023-06-01 12027503 dpl:Item1 2024-05-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12027503
England and Wales
J D MEDICAL SERVICES LTD
Unaudited Financial Statements
Period of accounts Start date: 01 June 2024 End date: 31 May 2025

J D MEDICAL SERVICES LTD Contents Page For the year ended 31 May 2025
Company information | 1
Statement of financial position | 2
Notes to the financial statements | 3

J D MEDICAL SERVICES LTD Company Information For the year ended 31 May 2025
Director | J A DAVIDSON
Registered Number | 12027503
Registered Office | C/O Goldwyns London Llp No.1 Royal Exchange, London United Kingdom EC3V 3DG
Accountants | Goldwyns London LLP No.1 Royal Exchange London EC3V 3DG
1

J D MEDICAL SERVICES LTD Statement of Financial Position As at 31 May 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 4 | 14,600 |  | 15,287
Investments | 5 | 20,305 |  | 20,305
|  | 34,905 |  | 35,592
Current assets |  |  |
Cash at bank and in hand |  | 69,777 |  | 12,981
Creditors: amount falling due within one year | 6 | (23,854) |  | (14,044)
Net current assets |  | 45,923 |  | (1,063)
Total assets less current liabilities |  | 80,828 |  | 34,529
Net assets |  | 80,828 |  | 34,529
Capital and reserves |  |  |
Called up share capital | 7 | 100 |  | 100
Profit and loss account |  | 80,728 |  | 34,429
Shareholders' funds |  | 80,828 |  | 34,529
For the year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 15 October 2025 and were signed by:
------------------------------- J A DAVIDSON Director
2

J D MEDICAL SERVICES LTD Notes to the Financial Statements For the year ended 31 May 2025
General Information J D MEDICAL SERVICES LTD is a private company, limited by shares, registered in England and Wales, registration number 12027503, registration address C/O Goldwyns London Llp, No.1 Royal Exchange, London, United Kingdom, EC3V 3DG. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Going concern basis The financial statements have been prepared on a going concern basis. The directors have considered the companys budgets, forecasts and available resources and are satisfied that the company has adequate resources to continue in operational existence for the foreseeable future. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset. Debtors and creditors receivable/ payable within one year Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
3. | Related Party Disclosure At the year end the company owed £3,651 (2024: £7,864) to a director. The balance is unsecured, interest free and repayable on demand.
4. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 June 2024 | 18,437 |  | 18,437
Additions | 4,564 |  | 4,564
Disposals | - |  | -
At 31 May 2025 | 23,001 |  | 23,001
Depreciation
At 01 June 2024 | 3,150 |  | 3,150
Charge for year | 5,251 |  | 5,251
On disposals | - |  | -
At 31 May 2025 | 8,401 |  | 8,401
Net book values
Closing balance as at 31 May 2025 | 14,600 |  | 14,600
Opening balance as at 01 June 2024 | 15,287 |  | 15,287
5. | Investments
Cost | Other investments other than loans |  | Total
| £ |  | £
At 01 June 2024 | 20,305 |  | 20,305
Additions | - |  | -
Disposals | - |  | -
At 31 May 2025 | 20,305 |  | 20,305
6. | Creditors: amount falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Other Creditors | 21,080 |  | 11,037
Deferred tax | 2,774 |  | 3,007
| 23,854 |  | 14,044
7. | Share Capital Authorised 100 Class A shares of £1.00 each
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
3